Security key
52187K101
- Security type / class
- Equity / COM
- Total 13F shares
- 41,873,407
- Total 13F value
- $167,914,000
- Share change
- +19,546,736
- SEC-reported price per share
- $4.01
- Number of holders
- 62
- Value change
- +$87,477,419
- Number of buys
- 47
- Number of sells
- 14
Report period
Q3 2021
Institutions
62
Top holders
10
LPTX full security history
Ownership snapshot
Full 13F holder table
CYPHERPUNK TECHNOLOGIES INC. SEC filings
CYPHERPUNK TECHNOLOGIES INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of LPTX - LEAP THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BeOne Medicines Ltd.
Disclosed value leader
BeOne Medicines Ltd.
Comparable rows
0/15
Latest evidence
24 Sep 2021
3/4/5
13F
Highest disclosed value: $20,943,045
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BeOne Medicines Ltd. has the largest disclosed position value at $20.94M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BeOne Medicines Ltd.'s linked filing trail.
Disclosed position value
Top 5
BeOne Medicines Ltd.
$20.94M
PERCEPTIVE ADVISORS LLC
$13.9M
HHLR ADVISORS, LTD.
$5.86M
Artal Group S.A.
$4.92M
VANGUARD GROUP INC
$3.45M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BeOne Medicines Ltd. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$20,943,045
7,348,437 shares
|
— | 24 Sep 2021 |
| PERCEPTIVE ADVISORS LLC |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$13,901,000
8,476,496 shares
|
— | 30 Jun 2021 |
| HHLR ADVISORS, LTD. |
13F
Company
|
—
denominator unverified
|
$5,864,000
3,575,745 shares
|
— | 30 Jun 2021 |
| Artal Group S.A. |
13F
Company
|
—
denominator unverified
|
$4,920,000
3,000,000 shares
|
— | 30 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$3,448,000
2,102,497 shares
|
— | 30 Jun 2021 |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
Company
|
—
denominator unverified
|
$1,492,000
910,047 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
62
Shares
41,873,407
Rows available
62
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
38
Q3 2021 holders
62
Holder diff
24
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|